Delivery Order HHSN271201400013I-75N95018F00005
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to Integrated Nonclinical Development Solutions Inc. (IND Solutions), a small business. The contract is for a SEND Explorer Plus license and annual maintenance, with a ceiling value of $117,500.00 and a period of performance ending on September 30, 2019. The contract was set aside for total small business participation. IND...
- This is a $3,397,876.27 cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, to IQ Solutions, Inc., a minority-owned, woman-owned small business. The contract provides support services for NIDA's International Research and Training Program, which aims to develop an international network of drug abuse researchers and facilitate global collaboration on drug abuse research. The contract includes...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development institute. The contract, valued at $175,508.78, is for non-rodent pharmacokinetic assessment services under NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract is a delivery order under the PTNP indefinite delivery vehicle (IDV) and has a cost-plus-fixed-fee pricing type. The contract does not...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order contract to Integrated Nonclinical Development Solutions Inc. (IND Solutions), a small business, for FY20 Annual SEND Explorer Warehouse and Technical Support. The contract has a potential value of $179,000.00 and a period of performance from August 1, 2020 to July 31, 2021. This contract was awarded under a total small business set-aside. IND Solutions, a...
- The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $16,000 purchase order to Cellx, Inc., a small business, on September 29, 2025, for pharmaceutics formulation, chemistry manufacturing and controls (CMC) consulting services supporting drug discovery and development programs. The contract, which runs through September 28, 2028, provides specialized subject matter expert consultation for small molecules and biologics development, with...
- The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), awarded a $12,645.00 Firm Fixed Price Delivery Order contract to JP Lawson Consulting, a small business, to provide consulting services under the Drug Consulting Blueprint Network contract vehicle. The contract has no set-aside designation and was awarded on September 21, 2018 with a final completion date of September 27, 2019. JP Lawson Consulting is the sole...
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), which is part of the U.S. Department of Health and Human Services, to Id Business Solutions Inc. The $171,564.81 purchase order contract is for a firm fixed price and is not set aside. Id Business Solutions Inc., doing business as Id Business Solutions, provides database and software solutions, particularly related to chemistry software and maintenance services, to support the National Institutes of Health's...
- This is a firm fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to JM Sisco Pharma Consulting, LLC, a small business entity. The contract, valued at $85,030.20, is for pharmaceutical consulting services related to chemical manufacturing and controls. The contract is part of the Drug Consulting Blueprint Network vehicle, which the contractor has consistently used to...
- The National Institute on Drug Abuse (NIDA), under the Department of Health and Human Services, awarded a $619,220 firm fixed-price purchase order to Instem LSS (North America) Limited for software licensing and support services. The contract, effective from September 29, 2025 through September 28, 2026, covers implementation and maintenance of Instem software modules including SEND Submit and Provantis at the National Center for Advancing Translational Sciences (NCATS). This non-competitive...
- This is a $4,026,071.62 cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, to SD Solutions LLC, an 8(a) small disadvantaged business based in Rockville, Maryland. The contract is for the NIDA Clinical Trials Research Coordination Center, which will provide logistical and operational support services for NIDA's National Drug Abuse Treatment Clinical Trials Network. This includes coordinating meetings,...
- Drug Consulting Blueprint NetworkMaster IDIQ
- HHSN271201400013IIndefinite Delivery Contract
- HHSN271201400013I-75N95018F00005Delivery Order
This federal contract award to Integrated Nonclinical Development Solutions Inc. (IND Solutions), a for-profit technology-enabled drug development and drug safety consultancy, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services. The $63,087.50 fixed-price Labor Hours contract is a Delivery Order under the Drug Consulting Blueprint Network master contract vehicle. IND Solutions will provide integrated nonclinical development solutions, including biosimulation, technology, and services to accelerate medicines to patients. This contract does not have a set-aside designation. IND Solutions has previously received other federal contract awards from NIDA and the Food and Drug Administration (FDA) to provide software, warehouse support and maintenance, and technical services in support of the agencies' drug development and safety missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | ($787) | 8/14/24 | |
| P00003 | Funding Only Action | $11.4k | 8/28/19 | |
| P00002 | Exercise an Option | $17.5k | 7/1/19 | |
| P00001 | Funding Only Action | $8.8k | 5/7/19 | |
| Not listed | Not listed | $26.3k | 9/17/18 |